Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 377,000 | 14,526,000 | 12,358,000 | 4,523,000 | 5,606,000 |
| Depreciation Amortization | 3,872,000 | 3,909,000 | 3,214,000 | 3,486,000 | 3,310,000 |
| Income taxes - deferred | -1,899,000 | -1,568,000 | 187,000 | -566,000 | -560,000 |
| Accounts receivable | -1,148,000 | -644,000 | -2,033,000 | -1,002,000 | 92,000 |
| Accounts payable and accrued liabilities | -380,000 | -289,000 | 405,000 | 684,000 | 443,000 |
| Other Working Capital | -2,205,000 | -2,782,000 | -3,839,000 | -4,601,000 | -2,077,000 |
| Other Operating Activity | 14,389,000 | 5,943,000 | 2,830,000 | 5,093,000 | 2,070,000 |
| Operating Cash Flow | $13,006,000 | $19,095,000 | $13,122,000 | $7,617,000 | $8,884,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 703,000 | -483,000 | 1,025,000 | 2,717,000 | 5,420,000 |
| PPE Investments | -3,863,000 | -4,388,000 | -4,448,000 | -4,429,000 | -3,369,000 |
| Net Acquisitions | -12,032,000 | -121,000 | -12,907,000 | -6,606,000 | -4,954,000 |
| Sale Of Investment | 1,145,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -36,000 | 32,000 | -91,000 | -875,000 | 374,000 |
| Investing Cash Flow | $-14,083,000 | $-4,960,000 | $-16,421,000 | $-9,193,000 | $-2,529,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -3,986,000 | 2,549,000 | -3,710,000 |
| Debt Issued | 5,939,000 | N/A | 7,936,000 | 4,419,000 | 4,958,000 |
| Debt Repayment | -1,755,000 | -2,251,000 | -2,319,000 | -1,957,000 | N/A |
| Common Stock Issued | 125,000 | 384,000 | 202,000 | 89,000 | 361,000 |
| Common Stock Repurchased | -1,346,000 | N/A | -840,000 | -1,281,000 | -4,780,000 |
| Dividend Paid | -7,445,000 | -7,012,000 | -6,610,000 | -6,215,000 | -5,695,000 |
| Other Financing Activity | -328,000 | -240,000 | 8,714,000 | -436,000 | 5,000 |
| Financing Cash Flow | $-4,810,000 | $-9,119,000 | $3,097,000 | $-2,832,000 | $-8,861,000 |
| Exchange Rate Effect | 23,000 | -410,000 | -133,000 | 253,000 | 17,000 |
| Beginning Cash Position | 12,773,000 | 8,167,000 | 8,153,000 | 9,934,000 | 7,967,000 |
| End Cash Position | 6,909,000 | 12,773,000 | 8,167,000 | 8,165,000 | 9,934,000 |
| Net Cash Flow | $-5,864,000 | $4,606,000 | $14,000 | $-1,769,000 | $1,967,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,006,000 | 19,095,000 | 13,122,000 | 7,617,000 | 8,884,000 |
| Capital Expenditure | -3,863,000 | -4,388,000 | -4,448,000 | -4,429,000 | -3,369,000 |
| Free Cash Flow | 9,143,000 | 14,707,000 | 8,674,000 | 3,188,000 | 5,515,000 |